← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2012Last known activity
Jul 25, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT03326102Overall official - principal investigatorPhase 2Jul 25, 2018
- NCT02053909Reponsible party - principal investigatorPhase 4Sep 1, 2014
- NCT02053909Lead sponsorPhase 4Sep 1, 2014
- NCT02053909Overall official - principal investigatorPhase 4Sep 1, 2014
- NCT01528709Overall official - principal investigatorPhase 3Mar 1, 2012
- NCT01528709Reponsible party - principal investigatorPhase 3Mar 1, 2012
- NCT01528709Lead sponsorPhase 3Mar 1, 2012
Details
- Last known activity
- Jul 25, 2018